Finance Forex

Merck Is Named No. 1 Pharma Pick at Bank of America

Merck Is Named No. 1 Pharma Pick At Bank Of America paragraph is one from those Finance, Forex sorts, written during our scripter Erick Emerson just after February 5, 2019, that essay can search upon those tags 1, America, Bank, Merck, Named, Pharma, Pick. We all pleased to satisfied you along with providing these other blogpost belonging finance moreover I'm always writting these post daily.

Bank of America Merrill Lynch on Tuesday named pharmaceutical giant Merck and Co.  (MRK) as its No. 1 top pick in the U.S. pharmaceutical space thanks to what it sees as strong potential upside in sales of one of its key cancer-treatment drugs.

On Friday, Merck reported that one of its key cancer drugs used to treat malignant tumors in lung and renal cancer surpassed $2 billion in its most recent quarter, exceeding analysts’ forecasts. The better-than-anticipated numbers pushed Merck shares higher last week, with the stock ending the week up close to 5%.

“The fourth-quarter and full-year results further bolster our confidence in Merck’s innovation-based strategy in which our key pillars – oncology, vaccines, animal health, and select hospital and specialty care products – are expected to drive sustainable growth over the long-term,” Merck CEO Kenneth Frazier said in Friday’s earnings release. “We enter 2019 with good momentum.”

That momentum is likely to continue, according to Bank of America Merrill Lynch analyst Jason Gerberry.

“Merck looks well positioned to become the preferred PD1 agent in most major tumor markets, and we estimate upcoming data readouts in lung and renal cancer have the potential to add $4 billion in peak sales or 5-10% upside,” Gerberry wrote in a note to clients.

Keytruda blocks a specific kind of protein called programmed death receptor 1, or PD-1, on immune cells, which helps keep the body’s cells from attacking other healthy cells. Sales of the drug surged 66% year over year in the fourth quarter, and accounted for nearly 20% of total sales.

Looking into 2019, Merck said it sees non-GAAP earnings of between $4.57 and $4.72 a share on global sales of between $43.2 billion and $44.7 billion, both topping estimates compiled by Refinitiv.

You might want to discover other essay finance with our related post or you maybe want to find out over well-liked chapter, I am always posting that finance part everyday for advise and suggest plus trick so sustaining our finance along with living the financial freedom. Those section is updated upon Erick Emerson with that title Merck Is Named No. 1 Pharma Pick At Bank Of America.

Related posts of "Merck Is Named No. 1 Pharma Pick at Bank of America"

Dutch government says in talks with 250 companies about Brexit move By Reuters

Dutch government says in talks with 250 companies about Brexit move AMSTERDAM (Reuters) - The Dutch government said on Saturday it was in talks with 250 companies about moving operations to the Netherlands from Britain ahead of Britain's exit from the European Union, scheduled for March 29. The Economic Affairs Ministry said in a report...

Here’s the candidate most likely to give Trump trouble

Getty Images Elizabeth Warren and Joe Biden may both vie for the Democratic presidential nominations.The Democratic field is big and getting bigger, and no one knows who will emerge as the nominee to take on President Trump next year. That being said, the last few months have provided some early clues—and plenty of...

China home prices slightly pick up in January

The latest data are for January, not December, and the comparison months should be December, not November. The months were misstated in four headlines beginning at 0405 GMT. "*China Dec Average New Home Prices Rise 10.8% on Year Vs. 10.6% in Nov" "*China Dec Average New Home Prices Rise 0.6% on Month Vs. 0.8% in...

Your partner’s credit score could reveal red flags that have nothing to do with money

Love & Money is a MarketWatch series looking at how our relationship with money impacts our relationships with significant others, friends and family. Many new couples inquire about a potential mate’s age or how many previous partners they’ve had. Others are more interested in another number. Approximately 42% of adults say knowing someone’s credit score...

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.